Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Troels Holz Borch

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

scientific article published on 26 September 2018

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types

scientific article published in October 2021

Cancer immunotherapy in patients with brain metastases.

scientific article published on 8 March 2018

Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study

scientific article

Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs

scientific article published on 07 January 2019

Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma

scientific article published on 01 July 2020

Immune Monitoring Using mRNA-Transfected Dendritic Cells.

scientific article

Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.

scientific article published on 22 March 2016

PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine.

scientific article published on July 2016

PD-L1-specific T cells.

scientific article published on 02 January 2016

Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma

scientific article published on 12 November 2020

Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies.

scientific article published on 16 July 2015

T cells isolated from patients with checkpoint inhibitor resistant-melanoma are functional and can mediate tumor regression.

scientific article published on 24 April 2018

mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma.

scientific article